As expected, trained CD3−CD56+ NK cells exhibited enhanced IFN-γ production in response to restimulation for 6 h with IL-12/15/18 on day 7 (Figure 1B) and exhibited more efficient killing toward K562 leukemia cells than was observed in the control group (Figure 1C). The gene discussed is IFNG; the disease is leukemia.